These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 36598092

  • 1. Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors.
    Tokalı FS, Demir Y, Türkeş C, Dinçer B, Beydemir Ş.
    Drug Dev Res; 2023 Apr; 84(2):275-295. PubMed ID: 36598092
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3H)-one derivatives as potential aldose reductase inhibitors.
    Tokalı FS, Demir Y, Demircioğlu İH, Türkeş C, Kalay E, Şendil K, Beydemir Ş.
    Drug Dev Res; 2022 May; 83(3):586-604. PubMed ID: 34585414
    [Abstract] [Full Text] [Related]

  • 3. Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study.
    El-Sayed S, Metwally K, El-Shanawani AA, Abdel-Aziz LM, El-Rashedy AA, Soliman MES, Quattrini L, Coviello V, la Motta C.
    Bioorg Med Chem Lett; 2017 Oct 15; 27(20):4760-4764. PubMed ID: 28935265
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
    Kucerova-Chlupacova M, Halakova D, Majekova M, Treml J, Stefek M, Soltesova Prnova M.
    Chem Biol Interact; 2020 Dec 01; 332():109286. PubMed ID: 33038328
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
    Wu B, Yang Y, Qin X, Zhang S, Jing C, Zhu C, Ma B.
    ChemMedChem; 2013 Dec 01; 8(12):1913-7. PubMed ID: 24115741
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
    Metwally K, Pratsinis H, Kletsas D, Quattrini L, Coviello V, Motta C, El-Rashedy AA, Soliman ME.
    Future Med Chem; 2017 Dec 01; 9(18):2147-2166. PubMed ID: 29098865
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S, Parveen S, Qin X, Hao X, Zhang S, Chen X, Zhu C, Ma B.
    Bioorg Med Chem Lett; 2014 May 01; 24(9):2086-9. PubMed ID: 24726808
    [Abstract] [Full Text] [Related]

  • 13. Design and synthesis of novel quinazolin-4(1H)-one derivatives as potent and selective inhibitors targeting AKR1B1.
    Han Z, Li J, Xu Z, Su Y, Wang Y, Zhuo L, Du J, Zhu C, Hao X.
    Arch Pharm (Weinheim); 2023 Apr 01; 356(4):e2200577. PubMed ID: 36707406
    [Abstract] [Full Text] [Related]

  • 14. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK, Sundaram K, Ravi S.
    Bioorg Chem; 2020 Apr 01; 97():103640. PubMed ID: 32086051
    [Abstract] [Full Text] [Related]

  • 15. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines.
    Sever B, Altıntop MD, Demir Y, Yılmaz N, Akalın Çiftçi G, Beydemir Ş, Özdemir A.
    Chem Biol Interact; 2021 Aug 25; 345():109576. PubMed ID: 34252406
    [Abstract] [Full Text] [Related]

  • 16. Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies.
    Bacha MM, Nadeem H, Zaib S, Sarwar S, Imran A, Rahman SU, Ali HS, Arif M, Iqbal J.
    BMC Chem; 2021 Apr 27; 15(1):28. PubMed ID: 33906691
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
    Reddy TN, Ravinder M, Bagul P, Ravikanti K, Bagul C, Nanubolu JB, Srinivas K, Banerjee SK, Rao VJ.
    Eur J Med Chem; 2014 Jan 27; 71():53-66. PubMed ID: 24275248
    [Abstract] [Full Text] [Related]

  • 18. Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies.
    Güleç Ö, Türkeş C, Arslan M, Demir Y, Dincer B, Ece A, İrfan Küfrevioğlu Ö, Beydemir Ş.
    Bioorg Chem; 2024 Apr 27; 145():107221. PubMed ID: 38387398
    [Abstract] [Full Text] [Related]

  • 19. (5-Hydroxy-4-oxo-2-styryl-4H-pyridin-1-yl)-acetic Acid Derivatives as Multifunctional Aldose Reductase Inhibitors.
    Chen H, Zhang X, Zhang X, Liu W, Lei Y, Zhu C, Ma B.
    Molecules; 2020 Nov 04; 25(21):. PubMed ID: 33158254
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase.
    Crespo I, Giménez-Dejoz J, Porté S, Cousido-Siah A, Mitschler A, Podjarny A, Pratsinis H, Kletsas D, Parés X, Ruiz FX, Metwally K, Farrés J.
    Eur J Med Chem; 2018 May 25; 152():160-174. PubMed ID: 29705708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.